Intellectual Property India Publishes Patent Application for '2-(Pyridazin-3-Yl)-5-(Trifluoromethyl)Phenols As Nlrp3 Inhibitors' Filed by Janssen Pharmaceutica NV

MUMBAI, India, Sept. 12 -- Intellectual Property India has published a patent application (202517078966 A) filed by Janssen Pharmaceutica NV, Beerse, Belgium, on Aug. 20, for '2-(pyridazin-3-yl)-5-(trifluoromethyl)phenols as nlrp3 inhibitors.'

Inventor(s) include Mammoliti, Oscar; Jerhaoui, Soufyan; Perez Benito, Laura; Caellas Roman, Santiago; Oehlrich, Daniel; Prieri, Marion Laurence Christiane; Muratore, Michael Eric; and Riccioli, Riccardo.

The application for the patent was published on Sept. 12, under issue no. 37/2025.

According to the abstract released by the Intellectual Property India: "Provided are compounds for use as inhibitors of the NLRP3 inflammasone pathway, wherein such compounds are as defined by compounds of formula (...